Positive Outcomes.
Positive Patient Stories.

Our Statement on COVID-19

We applaud the heroic efforts of medical professionals around the world who are working to protect public health and combat the COVID-19 pandemic. Whether directly treating patients impacted by the virus or implementing containment measures to constrain its transmission, you selflessly put the needs and journey of your patients first.

We at Paratek will strive to do our part during this crisis. As the global COVID-19 pandemic continues to evolve, we are providing an uninterrupted supply of our commercially available antibiotic, NUZYRA®.  In addition, we have sufficient inventory of NUZYRA to support our ongoing and planned clinical trials.

Paratek has also embraced the public health guidance regarding social distancing with all employees now working from home, utilizing a virtual model for meetings and interactions with the healthcare community and payers – even in areas where it isn’t being mandated.

Our medical team is standing by to address any questions you might have about the role of antibiotics in the treatment of bacterial pneumonias or secondary bacterial pneumonias. Please contact your local Medical Science Director or send an email to medinfo@paratekpharma.com if you have any questions or suggestions on ways Paratek can help in these efforts.

We are also sharing the following resources designed to help us all stay on top of current developments: https://www.nejm.org/coronavirus and https://www.thelancet.com/coronavirus.

On behalf of all of us, thank you for your tireless efforts to save lives.